论文信息 - TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects - 字舞流文

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects

A. Gudkov | G. Paszkiewicz | Gary J Haderski | Bojidar M Kandar | C. Brackett | Ilia M Toshkov | Christopher P. Johnson | Venkatesh Natarajan | A. Gleiberman | L. Burdelya | B. Kandar